Neurology
News
FDA will strengthen heart attack, stroke risk warnings for all NSAIDs
Conference Coverage
AHS: Noncephalic pain sites shed light on progression from episodic to chronic migraine
Location of noncephalic pain site, as well as the number of them, the frequency of pain, and intensity of pain, are useful indicators of the...
Conference Coverage
ASCP: Animal models, big data give mind/microbiome research a boost
Conference Coverage
Lithium, caffeine effective for hypnic headache treatment
Lithium is the most effective treatment for patients with chronic hypnic headache, followed by consumption of caffeine prior to bedtime and when...
Conference Coverage
Investigative agent effective against episodic migraine
The investigative agent AMG 334, administered in 70-mg doses, is an effective treatment for patients with episodic migraines, resulting in a...
Conference Coverage
Abundance of agents adds choice in choosing MS therapy
Conference Coverage
AHS: Intravenous diphenhydramine does not improve acute migraine outcomes
Intravenous diphenhydramine 50 mg combined with metoclopramide 10 mg IV did not induce a significantly improved sustained response, when compared...
Conference Coverage
AHS: Insomnia in migraineurs indicates anxiety, depression risk
Migraine patients who also experience insomnia are at an elevated risk for developing anxiety and depression, so health care providers should be...
News
Researchers pin down possible cause, source for narcolepsy associated with flu vaccine
Key clinical point:Nucleoprotein antibodies possibly explain influenza vaccine associated narcolepsy. Major finding: Patients with a history of...